Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
0455.HK Stock Summary
Top 10 Correlated ETFs
0455.HK
In the News
0455.HK Financial details
Company Rating
Neutral
Market Cap
580.51M
Income
-1.77M
Revenue
672.09M
Book val./share
0.28
Cash/share
0.1
Dividend
-
Dividend %
1.14%
Employees
820
Optionable
No
Shortable
Yes
Earnings
28 Aug 2023
P/E
-22.72
Forward P/E
-
PEG
2.44
P/S
0.97
P/B
0.78
P/C
2.6
P/FCF
-7.94
Quick Ratio
0.95
Current Ratio
1.54
Debt / Equity
0.18
LT Debt / Equity
0.05
-
-
EPS (TTM)
-0
EPS next Y
-
EPS next Q
-
EPS this Y
151.49%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
0.74%
Revenue Q/Q
147%
EPS Q/Q
-575%
-
-
-
-
SMA20
28.57%
SMA50
17.39%
SMA100
35%
Inst Own
-
Inst Trans
-
ROA
-2%
ROE
-3%
ROC
-0.05%
Gross Margin
47%
Oper. Margin
-8%
Profit Margin
-4%
Payout
-39%
Shs Outstand
2.15B
Shs Float
442.33M
-
-
-
-
Target Price
-
52W Range
0.173-0.28
52W High
-
52W Low
-
RSI
56.3
Rel Volume
4.73
Avg Volume
303.73K
Volume
1.44M
Perf Week
-5.45%
Perf Month
39.78%
Perf Quarter
28.71%
Perf Half Y
23.81%
-
-
-
-
Beta
0.099
-
-
Volatility
0.01%, 0.03%
Prev Close
-3.7%
Price
0.26
Change
-5.45%
0455.HK Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2019-03-31 | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2022-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.25 | 0.23 | 0.22 | 0.24 | 0.25 | |
Net income per share | 0 | 0 | -0.01 | -0.01 | -0.03 | |
Operating cash flow per share | 0.01 | -0.01 | -0.02 | 0 | 0.04 | |
Free cash flow per share | -0.01 | -0.06 | -0.09 | -0.03 | 0.03 | |
Cash per share | 0.21 | 0.14 | 0.11 | 0.16 | 0.16 | |
Book value per share | 0.36 | 0.34 | 0.35 | 0.35 | 0.29 | |
Tangible book value per share | 0.3 | 0.28 | 0.31 | 0.31 | 0.26 | |
Share holders equity per share | 0.36 | 0.34 | 0.35 | 0.35 | 0.29 | |
Interest debt per share | -0.01 | 0.01 | 0.07 | 0.07 | 0.07 | |
Market cap | 516.05M | 344.01M | 434.31M | 500.96M | 870.77M | |
Enterprise value | 131.14M | 67.22M | 344.85M | 327.39M | 671.54M | |
P/E ratio | 194.21 | 39.09 | -16.76 | -23.11 | -15.94 | |
Price to sales ratio | 0.98 | 0.7 | 0.92 | 0.98 | 1.59 | |
POCF ratio | 26.92 | -17.28 | -11.54 | -60.9 | 11.01 | |
PFCF ratio | -35.65 | -2.81 | -2.36 | -8.08 | 15.91 | |
P/B Ratio | 0.66 | 0.48 | 0.57 | 0.66 | 1.39 | |
PTB ratio | 0.66 | 0.48 | 0.57 | 0.66 | 1.39 | |
EV to sales | 0.25 | 0.14 | 0.73 | 0.64 | 1.23 | |
Enterprise value over EBITDA | 3.9 | 1.87 | -56.11 | -19.46 | -33.75 | |
EV to operating cash flow | 6.84 | -3.38 | -9.16 | -39.8 | 8.49 | |
EV to free cash flow | -9.06 | -0.55 | -1.87 | -5.28 | 12.27 | |
Earnings yield | 0.01 | 0.03 | -0.06 | -0.04 | -0.06 | |
Free cash flow yield | -0.03 | -0.36 | -0.42 | -0.12 | 0.06 | |
Debt to equity | -0.02 | 0.03 | 0.19 | 0.21 | 0.22 | |
Debt to assets | -0.01 | 0.03 | 0.13 | 0.14 | 0.13 | |
Net debt to EBITDA | -11.45 | -7.71 | 14.55 | 10.32 | 10.01 | |
Current ratio | 4.04 | 4.1 | 2.83 | 2.13 | 1.54 | |
Interest coverage | 0 | 43.79 | -47.01 | -53.74 | -9.37 | |
Income quality | 0.73 | -1.25 | 1.37 | 0.29 | -1.45 | |
Dividend Yield | 0.01 | 0.01 | 0.01 | 0.02 | 0.02 | |
Payout ratio | 2.56 | 0.24 | -0.1 | -0.39 | -0.32 | |
Sales general and administrative to revenue | 0.12 | 0.14 | 0.15 | 0.14 | 0.15 | |
Research and developement to revenue | 0.01 | 0 | 0.02 | 0.03 | 0.07 | |
Intangibles to total assets | 0.17 | 0.17 | 0.12 | 0.11 | 0.09 | |
Capex to operating cash flow | -1.76 | 5.14 | 3.89 | 6.54 | -0.31 | |
Capex to revenue | -0.06 | -0.21 | -0.31 | -0.11 | -0.04 | |
Capex to depreciation | -2.08 | -5.24 | -7.1 | -2.43 | -0.49 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 0.1 | 0.18 | 0.31 | 0.28 | 0.41 | |
ROIC | 0.01 | 0.01 | -0.03 | -0.03 | -0.08 | |
Return on tangible assets | 0 | 0.01 | -0.03 | -0.02 | -0.06 | |
Graham Net | 0.23 | 0.11 | 0.02 | 0.01 | 0.02 | |
Working capital | 542.33M | 448.82M | 392.18M | 305.79M | 195.75M | |
Tangible asset value | 639.4M | 598.43M | 659.44M | 660.92M | 552.17M | |
Net current asset value | 534.69M | 420.46M | 263.44M | 202.37M | 123.95M | |
Invested capital | -0.02 | 0.03 | 0.19 | 0.21 | 0.22 | |
Average receivables | 142.97M | 189.36M | 120.46M | 74.07M | 71.41M | |
Average payables | 24.5M | 30.3M | 58.35M | 96.54M | 88.26M | |
Average inventory | 42.55M | 48.58M | 56.38M | 69.64M | 61.54M | |
Days sales outstanding | 198.04 | 68.9 | 114 | 0 | 95.35 | |
Days payables outstanding | 112.78 | 80.57 | 149.01 | 142.85 | 88.22 | |
Days of inventory on hand | 172.98 | 135.34 | 109.14 | 101.72 | 59.59 | |
Receivables turnover | 1.84 | 5.3 | 3.2 | 0 | 3.83 | |
Payables turnover | 3.24 | 4.53 | 2.45 | 2.56 | 4.14 | |
Inventory turnover | 2.11 | 2.7 | 3.34 | 3.59 | 6.12 | |
ROE | 0 | 0.01 | -0.03 | -0.03 | -0.09 | |
Capex per share | -0.02 | -0.05 | -0.07 | -0.03 | -0.01 |
Quarterly Fundamentals Overview
Last date of statement is 2023-06-30 for Q1
Metric | History | 2021-03-31 | 2021-09-30 | 2022-03-31 | 2022-09-30 | 2023-06-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0 | 0 | 0 | 0 | 0.14 | |
Net income per share | 0 | 0 | 0 | 0 | 0 | |
Operating cash flow per share | 0 | 0 | 0 | 0 | -0.02 | |
Free cash flow per share | 0 | 0 | 0 | 0 | -0.04 | |
Cash per share | 0 | 0 | 0 | 0 | 0.1 | |
Book value per share | 0 | 0 | 0 | 0 | 0.28 | |
Tangible book value per share | 0 | 0 | 0 | 0 | 0.23 | |
Share holders equity per share | 0 | 0 | 0 | 0 | 0.28 | |
Interest debt per share | 0 | 0 | 0 | 0 | 0.05 | |
Market cap | 0 | 0 | 0 | 0 | 468.71M | |
Enterprise value | -89.45M | -37.78M | -173.57M | -72.67M | 388.57M | |
P/E ratio | 0 | 0 | 0 | 0 | -28.39 | |
Price to sales ratio | 0 | 0 | 0 | 0 | 1.54 | |
POCF ratio | 0 | 0 | 0 | 0 | -9.06 | |
PFCF ratio | 0 | 0 | 0 | 0 | -5.14 | |
P/B Ratio | 0 | 0 | 0 | 0 | 0.78 | |
PTB ratio | 0 | 0 | 0 | 0 | 0.78 | |
EV to sales | 0 | 0 | 0 | 0 | 1.28 | |
Enterprise value over EBITDA | 0 | 0 | 0 | 0 | 36.4 | |
EV to operating cash flow | 0 | 0 | 0 | 0 | -7.51 | |
EV to free cash flow | 0 | 0 | 0 | 0 | -4.27 | |
Earnings yield | 0 | 0 | 0 | 0 | -0.01 | |
Free cash flow yield | 0 | 0 | 0 | 0 | -0.19 | |
Debt to equity | 0.19 | 0.22 | 0.21 | 0.25 | 0.18 | |
Debt to assets | 0.13 | 0.15 | 0.14 | 0.16 | 0.11 | |
Net debt to EBITDA | 0 | 0 | 0 | 0 | -7.51 | |
Current ratio | 2.83 | 2.85 | 2.13 | 2.09 | 1.32 | |
Interest coverage | 0 | 0 | 0 | 0 | -2.44 | |
Income quality | 0 | 0 | 0 | 0 | 12.54 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0.03 | |
Intangibles to total assets | 0.12 | 0.12 | 0.11 | 0.13 | 0.14 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0.76 | |
Capex to revenue | 0 | 0 | 0 | 0 | -0.13 | |
Capex to depreciation | 0 | 0 | 0 | 0 | -2.23 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 0 | 0 | 0 | 0 | 0.11 | |
ROIC | 0 | 0 | 0 | 0 | -0.01 | |
Return on tangible assets | 0 | 0 | 0 | 0 | 0 | |
Graham Net | 0 | 0 | 0 | 0 | 0 | |
Working capital | 392.18M | 374.77M | 305.79M | 247.58M | 97.71M | |
Tangible asset value | 659.44M | 636.88M | 660.92M | 538.92M | 487.22M | |
Net current asset value | 263.44M | 229.11M | 202.37M | 140.47M | 63.3M | |
Invested capital | 0.19 | 0.22 | 0.21 | 0.25 | 0.18 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 0 | 0 | 0 | 0 | 0 | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 0 | 0 | 0 | 0 | 33.31 | |
Days payables outstanding | 0 | 0 | 0 | 0 | 63.37 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 40.74 | |
Receivables turnover | 0 | 0 | 0 | 0 | 2.7 | |
Payables turnover | 0 | 0 | 0 | 0 | 1.42 | |
Inventory turnover | 0 | 0 | 0 | 0 | 2.21 | |
ROE | 0 | 0 | 0 | 0 | -0.01 | |
Capex per share | 0 | 0 | 0 | 0 | -0.02 |
0455.HK Frequently Asked Questions
What is Tianda Pharmaceuticals Limited stock symbol ?
Tianda Pharmaceuticals Limited is a HK stock and trading under the symbol 0455.HK
What is Tianda Pharmaceuticals Limited stock quote today ?
Tianda Pharmaceuticals Limited stock price is $0.26 today.
Is Tianda Pharmaceuticals Limited stock public?
Yes, Tianda Pharmaceuticals Limited is a publicly traded company.